Skip to main content
. 2006 Feb 7;107(11):4250–4256. doi: 10.1182/blood-2005-11-4406

Figure 2.

Figure 2.

A 2-log drop in BCR-ABL mRNA at the time of CCR predicts better progression-free survival. The cumulative rate of progression-free survival (Kaplan-Meier method) is shown for those subjects achieving, versus not achieving, a minimal 2.0 log-drop in BCR-ABL mRNA at the time of first CCR.